Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-06-16
1998-07-07
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 514 16, 514 17, 514 18, 530317, 530327, 530328, 530329, 530330, 530345, A61K 3807, A61K 3808, A61K 3812, C07K 706
Patent
active
057768927
ABSTRACT:
The present invention relates to peptides, peptide analogs and peptide derivatives related to platelet factor 4 which exhibit anti-inflammatory activity, to pharmaceutical compositions comprising said peptides, and to methods of inhibiting inflammation utilizing the peptides of the invention.
REFERENCES:
patent: 4461724 (1984-07-01), Konishi
patent: 4585755 (1986-04-01), Morgan et al.
patent: 4645828 (1987-02-01), Twardzik
patent: 4703034 (1987-10-01), Freidinger et al.
patent: 4719288 (1988-01-01), Fuhrer et al.
patent: 4816449 (1989-03-01), Hahn
patent: 4816560 (1989-03-01), Verdini et al.
patent: 5086164 (1992-02-01), Maione
patent: 5141851 (1992-08-01), Brown et al.
patent: 5358934 (1994-10-01), Borovsky et al.
patent: 5386011 (1995-01-01), Wiedeman et al.
patent: 5411942 (1995-05-01), Widmer er al.
patent: 5436222 (1995-07-01), Kuna et al.
patent: 5470831 (1995-11-01), Whitman et al.
Banda et al., 1982, Isolation of a nonmitogenic angiogenesis factor from wound fluid, Proc. Natl. Acad. Sci. USA 79:7773-77.
Barone et al., 1991, Polymorphonuclear Leukocyte Infiltration Into Cerebral Focal Ischemic Tissue: Myeloperoxidase Activity Assay and Histologic Verification, J. Neurosci. Res. 29:336-45.
Bebawy et al., 1986, In Vitro Effects of Platelet Factor 4 on Normal Human Neutrophil Functions, J. Leukocyte Biol. 39:423-34.
Bernstein et al., 1982, Migration of Cultured Vascular Cells in Response to Plasma and Platelet-Derived Factors, J. Cell Sci. 56:71-82.
Blackwell et al., 1980, Macrocortin: A Polypeptide Causing the Anti-phospholipase Effect of Glucocorticoids, Nature 287:147-49.
Browne & Leslie, 1976, Animal Models of Peritonitis, Surg. Gynecol. Obstet. 143:738-40.
Broxmeyer et al., 1993, Comparative Analysis of the Human Macrophage Inflammatory Protein Family of Cytokines (Chemokines) on Proliferation of Human Myeloid Progenitor Cells, J. Immunol. 150:3448-58.
Cella et al., 1986, Platelet Factor 4 (PF4) and Heparin Released Platelet Factor 4 (HR-PF4) in Diabetes Mellitus Effect of the Duration of the Disease, Folia Haematol. 113:646-54.
Ciaglowski et al., 1986, Isolation and Amino Acid Sequence of Bovine Platelet Factor 4, Arch. Biochem. and Biophy. 250:249-56.
Cortellaro et al., 1990, High Heparin Released Platelet Factor 4 in Uncomplicated Type 1 Diabetes Mellitus, Thromb. Res. 58:571-76.
Diezel et al., 1989, Inhibition of Cutaneous Contact Hypersensitivity by Calcium Transport Inhibitors Lanthanum and Diltiazem, J. Invest. Dermatol. 93:322-26.
Doherty et al., 1988, Multiple Topical Applications of Arachidonic Acid to Mouse Ears Induce Inflammatory and Proliferative Changes, J. Invest. Derm. 91:298-302.
Edgington, 1993, Chemokines in Cardiovascular Disease, Bio/Technol. 11:676-81.
Eisman et al., 1990, Structural and Functional Comparison of the Genes for Human Platelet Factor 4 and PF4.sub.alt, Blood 76:336-44.
Filipp et al., 1984, Effect of Highly Radiolabelled 2,4-Dinitrochlorobenzene (DNCB) on Experimental DNCB Contact Dermatitis in Guinea Pigs, Allergy 39:499-507.
Gimbrone et al., 1974, Tumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornea, J. Nat'l Cancer Inst. 52:413-427.
Griswold et al., 1991, Pharmacology of the Pyrroloimidazole, SK&F 105809-II; Antiinflammatory Activity and Inhibition of Mediator Production In Vivo, Biochem. Pharmacol. 42:825-31.
Guastamacchia et al., 1985, PF, VIII/vWF, B-TG and PF.sub.4 In Diabetic Subjects, Both Type 1 and 2, With and Without Retinopathy, Boll. Soc. It. Biol. 61:499-505.
Hanna et al., 1990, Pharmacological Profile of SK&F 105809, A Dual Inhibitor of Arachidonic Acid Metabolism, Drugs Exptl. Clin. Res. 16:137-47.
Johansson et al., 1993, Speculations around the Mechanism behind the Action of Peptide T in the Healing of Psoriasis: A Minireview, Acta Derm Venereol (Stockh) 73:401-403.
Johansson et al., 1994, Somatostatin Immunoreactive Cells in Lesional Psoriatic Human Skin during Peptide T Treatment, Acta Derm Venereol (Stockh) 74:106-109.
Kragballe & Voorhees, 1985, Arachidonic Acid and Leukotrienes in Clinical Dermatology, Curr. Probl. Derm. 13:1-10.
Medici et al., 1989, Improved Method for Purification of Human Platelet Factor 4 by Affinity and Ion-Exchange Chromatography, Thromb. Res. 54:277-87.
Obal et al., 1990, Interleukin 1.alpha. and an interleukin 1.beta. fragment are somnogenic, Am. J. Physiol. 259:R439-46.
Rybak et al., 1989, Interaction of Platelet Factor Four With Cultured Vascular Endothelial Cells, Blood 73:1534-39.
Schmitz-Huebner & Knop, 1984, Evidence for an Endothelial Cell Dysfunction in Association with Behcet's Disease, Thromb. Res. 34:277-85.
Weerasinghe et al., 1984, Inhibition of the Cerebroside Sulphate (Sulphatide)-Induced Contact Activation Reactions by Platelet Factor Four, Thromb. Res. 33:625-31.
Wei & Thomas, 1993, Anti-Inflammatory Peptide Agonists, Annu. Rev. Pharmacol. Toxicol. 33:91-108.
Wooley, 1988, Collagen-Induced Arthritis in the Mouse, Meth. Enzym. 162:361-73.
Young et al., 1984, The Mouse Ear Inflammatory Response to Topical Arachidonic Acid, J. Invest. Derm. 82:367-71.
Zucker et al., 1989, Immunoregulatory Activity of Peptides Related to Platelet Factor 4, Proc. Natl. Acad. Sci. USA 86:7571-74.
Counts David F.
Duff Ronald G.
Curative Health Services, Inc.
Russel Jeffrey E.
LandOfFree
Anti-inflammatory peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-inflammatory peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1205875